Research interests
CABANA-AF Trial award from the National Institutes of Health[8]
2009 to 2017
TD
Tristram Dan Bahnson is a Duke Professor of Medicine whose work has helped shape evidence on catheter ablation and atrial fibrillation treatment. He completed a B.Sc. (hons) at Brown University in 1979, earned an M.D. from the University of California San Francisco in 1984, completed residency at UC Davis from 1984 to 1986, and trained in cardiology at UC San Diego from 1989 to 1994. His research spans randomized atrial fibrillation treatment comparisons, ablation safety, ventricular arrhythmia mapping, conduction-system pacing, and imaging for real-time lesion assessment. His current portfolio includes the NIH-funded CABANA-HF study, focused on catheter ablation versus drug and heart-failure therapy in preserved-ejection-fraction heart failure.
Each topic is linked to its supporting source in Sources.
Training includes Fellow in Cardiology at University of California, San Diego, Medical Resident at University of California, Davis, B.Sc. (hons) at Brown University, and Discussed the article "Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial.", plus 7 more records.
Explore education and trainingAs of 1994
As of 1986
As of 1979
As of 2022
Completed 1984
CABANA-AF Trial award from the National Institutes of Health[8]
2009 to 2017
CABANA-HF award from the National Institutes of Health[8]
2026 to 2033
Clinical evaluation of ultrasound-guided cardiac ablation award from the National Institutes of Health[8]
2010 to 2016
Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective Study[8]
From 2023
Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial[8]
From 2023
Incessant device-initiated wide complex tachycardia: What is the mechanism?[8]
From 2025
Multimodal ultrasound imaging for cardiac ablation award from the National Institutes of Health[8]
2007 to 2011
Multiscale Modeling of Clotting Risk in Atrial Fibrillation award from the University of North Carolina at Chapel Hill[8]
2018 to 2023
PRECEPT award from Biosense Webster Inc[8]
2017 to 2019
Prognostic Impact of Sinus Rhythm in Atrial Fibrillation Patients: Separating Rhythm Outcomes From Randomized Strategy Findings From the CABANA Trial[8]
From 2024
QDOT MICRO catheter evaluation award from Biosense Webster Inc[8]
2019 to 2022
Radiofrequency-ablation predictive-modeling award from St. Jude Medical Inc[8]
2015 to 2018
Regional differences in outcomes with ablation versus drug therapy for atrial fibrillation: Results from the CABANA trial[8]
From 2024
Repeat catheter ablation for atrial fibrillation[8]
From 2024
Reply to: Two ripples in a pond: The subtleties of mapping observations in localizing PVC sites[8]
From 2023
Same-Day Discharge in Ventricular Ablation: Safety Outcomes and Case Selection[8]
From 2026
Use of a Stylet Driven Lead With a Flexible Neck for Left Bundle Branch Area Pacing: A Single Center Experience[8]
From 2025
Use of Ripple mapping to enhance localization and ablation of outflow tract premature ventricular contractions[8]
From 2023